<DOC>
	<DOC>NCT00097422</DOC>
	<brief_summary>The purpose of this study is to investigate the safety and perform preliminary clinical evaluation in patients with mild to moderate CDAD.</brief_summary>
	<brief_title>OPT-80 in Clostridium Difficile-Associated Diarrhea (CDAD)</brief_title>
	<detailed_description>This is a dose-finding study to select a safe and efficacious dose of OPT-80. Patients will be evaluated for safety and efficacy and pharmacokinetic parameters will be investigated.</detailed_description>
	<mesh_term>Diarrhea</mesh_term>
	<criteria>Patients with CDAD Patients with severe CDAD</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>CDAD, diarrhea</keyword>
	<keyword>Clostridium difficile-Associated Diarrhea</keyword>
</DOC>